When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Health Canada approves Lundbeck's (HLUKF) Vyepti (eptinezumab) for the preventive treatment of migraine in adults who have at least 4 migraine days per month, making it the first Health Canada-approved intravenous ((IV)) treatment for migraine prevention.Vyepti is a humanized monoclonal antibody that binds to calcitonin gene-related peptide which was purposefully developed for IV administration.